JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258843

Human DGUOK (dGK) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

DGUOK KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

View Alternative Names

Deoxyguanosine kinase mitochondrial, dGK

1 Images
Sanger Sequencing - Human DGUOK (dGK) knockout HEK-293T cell lysate (AB258843)
  • Sanger seq

Unknown

Sanger Sequencing - Human DGUOK (dGK) knockout HEK-293T cell lysate (AB258843)

Homozygous : 1 bp insertion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258843-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human DGUOK knockout HEK293T cell lysate", "number":"AB258843-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258843-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
DGUOK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The target 'dGK' also known as deoxyguanosine kinase is an enzyme that plays an important role in the salvage pathway of nucleotide synthesis. It is a mitochondrial kinase with a known mass of approximately 29 kDa. The enzyme catalyzes the phosphorylation of purine deoxyribonucleosides such as deoxyguanosine to their monophosphate forms. dGK is expressed mainly in mitochondria-rich tissues like the liver muscle and brain indicating its importance in nucleoside metabolism in these areas.
Biological function summary

Deoxyguanosine kinase contributes significantly to the maintenance of mitochondrial DNA by ensuring the supply of deoxyribonucleotide triphosphates (dNTPs). It does not function as part of a larger protein complex working independently to convert purine deoxynucleosides in a rate-limiting step. The enzyme ensures that cellular processes requiring DNA replication and repair can proceed highlighting its importance in cellular functionality and homeostasis.

Pathways

Deoxyguanosine kinase participates in the nucleotide salvage pathway which is pivotal for recycling nucleosides into nucleotide pools. This pathway complements the de novo synthesis pathway providing a rapid response mechanism for nucleotide demand. dGK operates alongside other kinases like thymidine kinase which similarly act to phosphorylate nucleosides. This interconnection facilitates the balance of nucleotide pools within the cell important for effective DNA synthesis and repair.

Mutations or deficiencies in deoxyguanosine kinase can lead to mitochondrial DNA depletion syndromes. Such conditions result in a variety of clinical manifestations including muscle weakness and neurological issues. dGK is linked to disorders like mitochondrial neurogastrointestinal encephalopathy where faulty dNTP pools cause progressive multisystemic symptoms. The disturbance in deoxyguanosine kinase’s function emphasizes its role in maintaining cellular energy homeostasis and genome integrity.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com